Frontiers in cellular and infection microbiologyAug 20, 2026

Post-COVID reactivation of chickenpox virus linked to weakened immune control

Long Covid Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated Aug 21, 2026

Abstract

SARS-CoV-2 infection is associated with a modest increase in herpes zoster (HZ) cases, particularly after severe COVID-19 or hospitalization.

Aging and immunosuppression are established risk factors for herpes zoster due to varicella-zoster virus reactivation.
Observational studies suggest a link between COVID-19 and increased HZ incidence, especially in the early post-infection period.
The evidence points to a potential narrowing of the immune control reserve needed to maintain varicella-zoster virus latency following SARS-CoV-2 infection.
Disruption of cellular immune function, interferon regulation, and inflammation could contribute to this effect, particularly in individuals with existing health conditions.
Long COVID may offer insights into persistent immune dysregulation, but its role as a direct cause of VZV disease is not yet established.
Post-COVID herpes zoster may indicate a breakdown in the balance between the host and the virus in vulnerable populations.

Simplified

Herpes zoster (HZ) is the clinically apparent manifestation of latent varicella-zoster virus (VZV) reactivation. Aging and immunosuppression are established risk contexts. SARS-CoV-2 infection has prompted renewed attention to whether acute or post-acute immune changes can reduce the reserve needed to maintain VZV latency. Large observational studies report a modest increase in HZ after COVID-19, most consistently after severe disease or hospitalization and within early post-infection windows. These associations do not establish direct causation or a population-wide shift of HZ toward younger adults. A threshold-lowering interpretation is more consistent with the available evidence: SARS-CoV-2 infection may narrow latency-control reserve through cellular immune disruption, interferon dysregulation, and inflammation, particularly in hosts already affected by comorbidity or treatment-related immunosuppression. Long COVID provides a setting in which persistent immune dysregulation can be studied, but it is not yet a proven causal framework for VZV disease. Post-COVID HZ may therefore represent a clinically visible manifestation of disrupted host-virus homeostasis in susceptible individuals. Prospective studies that combine clinical phenotyping with VZV-specific cellular immune measurements are needed to test this model.

Full Text

Full text is available at the source.

View Full Text ↗

Post-COVID reactivation of chickenpox virus linked to weakened immune control

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the long covid brief